1-12 of 12
J Wijdenes
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Myeloma cell growth arrest, apoptosis, and interleukin-6 receptor modulation induced by EB1089, a vitamin D3 derivative, alone or in association with dexamethasone

D Puthier, R Bataille, S Barille, MP Mellerin, JL Harousseau, A Ponzio, N Robillard, J Wijdenes, M Amiot
Journal: Blood
Blood (1996) 88 (12): 4659–4666.
https://doi.org/10.1182/blood.V88.12.4659.bloodjournal88124659
Published: 1996
Journal Articles

Interleukin-10 is a growth factor for human myeloma cells by induction of an oncostatin M autocrine loop

ZJ Gu, V Costes, ZY Lu, XG Zhang, V Pitard, JF Moreau, R Bataille, J Wijdenes, JF Rossi, B Klein
Journal: Blood
Blood (1996) 88 (10): 3972–3986.
https://doi.org/10.1182/blood.V88.10.3972.bloodjournal88103972
Published: 1996
Journal Articles

Release of interleukin-12 in experimental Escherichia coli septic shock in baboons: relation to plasma levels of interleukin-10 and interferon- gamma

PM Jansen, TC van der Pouw Kraan, IW de Jong, G van Mierlo, J Wijdenes, AA Chang, LA Aarden, FB Jr. Taylor, CE Hack
Journal: Blood
Blood (1996) 87 (12): 5144–5151.
https://doi.org/10.1182/blood.V87.12.5144.bloodjournal87125144
Published: 1996
Journal Articles

Measurement of whole body interleukin-6 (IL-6) production: prediction of the efficacy of anti-IL-6 treatments

ZY Lu, H Brailly, J Wijdenes, R Bataille, JF Rossi, B Klein
Journal: Blood
Blood (1995) 86 (8): 3123–3131.
https://doi.org/10.1182/blood.V86.8.3123.3123
Published: 1995
Journal Articles

Biologic effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma

R Bataille, B Barlogie, ZY Lu, JF Rossi, T Lavabre-Bertrand, T Beck, J Wijdenes, J Brochier, B Klein
Journal: Blood
Blood (1995) 86 (2): 685–691.
https://doi.org/10.1182/blood.V86.2.685.bloodjournal862685
Published: 1995
Journal Articles

Interleukin-10 is a proliferation factor but not a differentiation factor for human myeloma cells

ZY Lu, XG Zhang, C Rodriguez, J Wijdenes, ZJ Gu, B Morel-Fournier, JL Harousseau, R Bataille, JF Rossi, B Klein
Journal: Blood
Blood (1995) 85 (9): 2521–2527.
https://doi.org/10.1182/blood.V85.9.2521.bloodjournal8592521
Published: 1995
Journal Articles

Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cells

C Pellat-Deceunynck, R Bataille, N Robillard, JL Harousseau, MJ Rapp, N Juge- Morineau, J Wijdenes, M Amiot
Journal: Blood
Blood (1994) 84 (8): 2597–2603.
https://doi.org/10.1182/blood.V84.8.2597.2597
Published: 1994
Journal Articles

Administration of an anti-interleukin-6 monoclonal antibody to patients with acquired immunodeficiency syndrome and lymphoma: effect on lymphoma growth and on B clinical symptoms

D Emilie, J Wijdenes, C Gisselbrecht, B Jarrousse, E Billaud, JY Blay, J Gabarre, JP Gaillard, J Brochier, M Raphael
Journal: Blood
Blood (1994) 84 (8): 2472–2479.
https://doi.org/10.1182/blood.V84.8.2472.2472
Published: 1994
Journal Articles

Role of interleukin-6 in paraneoplastic thrombocytosis [letter]

JY Blay, M Favrot, JF Rossi, J Wijdenes
Journal: Blood
Blood (1993) 82 (7): 2261–2262.
https://doi.org/10.1182/blood.V82.7.2261.2261
Published: 1993
Journal Articles

Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease

P Herve, M Flesch, P Tiberghien, J Wijdenes, E Racadot, P Bordigoni, E Plouvier, JL Stephan, H Bourdeau, E Holler
Journal: Blood
Blood (1992) 79 (12): 3362–3368.
https://doi.org/10.1182/blood.V79.12.3362.3362
Published: 1992
Journal Articles

Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia

B Klein, J Wijdenes, XG Zhang, M Jourdan, JM Boiron, J Brochier, J Liautard, M Merlin, C Clement, B Morel-Fournier
Journal: Blood
Blood (1991) 78 (5): 1198–1204.
https://doi.org/10.1182/blood.V78.5.1198.1198
Published: 1991
Journal Articles

Treatment of corticosteroid resistant acute graft-versus-host disease by in vivo administration of anti-interleukin-2 receptor monoclonal antibody (B-B10) [see comments]

P Herve, J Wijdenes, JP Bergerat, P Bordigoni, N Milpied, JY Cahn, C Clement, R Beliard, B Morel-Fourrier, E Racadot
Journal: Blood
Blood (1990) 75 (4): 1017–1023.
https://doi.org/10.1182/blood.V75.4.1017.1017
Published: 1990